Huifang Sun Selected Research

cancer procoagulant

4/2021	Pharmacokinetics and Pharmacodynamics of a Depolymerized Glycosaminoglycan from Holothuria fuscopunctata, a Novel Anticoagulant Candidate, in Rats by Bioanalytical Methods.
4/2020	Effects of Native Fucosylated Glycosaminoglycan, Its Depolymerized Derivatives on Intrinsic Factor Xase, Coagulation, Thrombosis, and Hemorrhagic Risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huifang Sun Research Topics

Disease

7	Neoplasms (Cancer) 11/2022 - 01/2011
5	Hemorrhage 04/2021 - 02/2018
3	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2016
2	Parkinson Disease (Parkinson's Disease) 07/2021 - 12/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2021
2	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2021 - 12/2019
2	Thrombosis (Thrombus) 01/2021 - 04/2020
2	Inflammation (Inflammations) 12/2020 - 09/2011
2	Neuroblastoma 01/2020 - 01/2020
2	Parkinsonian Disorders (Parkinsonism) 10/2018 - 12/2017
2	Noise-Induced Hearing Loss (Acoustic Trauma) 09/2011 - 01/2011
1	Lentivirus Infections 11/2022
1	Ataxia (Dyssynergia) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021
1	Cognitive Dysfunction 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Carcinogenesis 01/2020
1	Infections 01/2019
1	Fahr's disease 01/2019
1	Pathologic Processes 12/2018
1	Edema (Dropsy) 11/2018
1	Bone Resorption 01/2017
1	Triple Negative Breast Neoplasms 10/2016
1	Wounds and Injuries (Trauma) 01/2011

Drug/Important Bio-Agent (IBA)

5	AnticoagulantsIBA 04/2021 - 02/2018
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2011
3	Long Noncoding RNAIBA 01/2020 - 01/2020
2	cancer procoagulantIBA 04/2021 - 04/2020
2	GlycosaminoglycansIBA 01/2021 - 04/2020
2	Growth Hormone (Somatotropin)IBA 09/2011 - 01/2011
1	Small Interfering RNA (siRNA)IBA 11/2022
1	diphosphoric acid (pyrophosphoric acid)IBA 11/2022
1	phosphohistidineIBA 11/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2022
1	heparanaseIBA 01/2021
1	matrigelIBA 01/2021
1	Ataxin-3IBA 01/2021
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2021
1	OligosaccharidesIBA 01/2021
1	Toll-Like Receptor 4IBA 12/2020
1	Intrinsic Factor FDA Link 04/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2020
1	multidrug resistance-associated protein 1IBA 01/2020
1	FIIaIBA 01/2020
1	Small Nucleolar RNA (snoRNA)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Adenine FDA LinkGeneric 12/2019
1	CytosineIBA 12/2019
1	GuanineIBA 12/2019
1	Ghrelin ReceptorsIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	PrionsIBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	Factor XIII (Coagulation Factor XIII)IBA 12/2018
1	Dinoprostone (PGE2)FDA Link 11/2018
1	Malondialdehyde (Propanedial)IBA 11/2018
1	CarrageenanIBA 11/2018
1	PTEN-induced putative kinaseIBA 10/2018
1	Protein Deglycase DJ-1IBA 10/2018
1	Adenosine Triphosphatases (ATPase)IBA 10/2018
1	Heparin (Liquaemin)FDA LinkGeneric 02/2018
1	Transcription Factors (Transcription Factor)IBA 12/2017
1	LigandsIBA 01/2017
1	OsteoprotegerinIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 10/2016
1	Biological ProductsIBA 09/2011
1	Messenger RNA (mRNA)IBA 01/2011
1	BuffersIBA 01/2011

Therapy/Procedure

2	Therapeutics 01/2019 - 07/2016
1	Autologous Transplantation 07/2021
1	Activities of Daily Living (ADL) 01/2021
1	Aftercare (After-Treatment) 01/2020
1	Radiotherapy 10/2016